Open AccessEffect of 52 % low-sodium salt applied to CM-DASH Diet on atherosclerotic cardiovascular disease risks in patients with hypertension and type-2 diabetes
Author(s) -
Jie Tang,
Dan Chen,
Lisha Mu,
Pingping Yu,
Tao Gong,
Huini Xu,
Ziyan Zhang,
Shuwen Cai,
Lihong Mu,
Ying Mei
Publication year - 2022
Publication title -
nutrición hospitalaria
Language(s) - English
Resource type - Journals
eISSN - 1699-5198
pISSN - 0212-1611
DOI - 10.20960/nh.04081
Subject(s) - dash , medicine , dash diet , diabetes mellitus , type 2 diabetes , sodium , type 2 diabetes mellitus , low sodium , disease , endocrinology , blood pressure , chemistry , organic chemistry , computer science , operating system
hypertension and diabetes are chronic disorders associated with an increased risk of cardiovascular disease. Objectives: to evaluate the effect of 52 % low-sodium salt applied to the Chinese-modified DASH (CM-DASH) diet on risk of atherosclerotic cardiovascular disease (ASCVD) in patients with hypertension and type-2 diabetes. Methods: the low-sodium salt group (LSSG) took 5 g/day of 52 % low-sodium salt plus CM-DASH diet for 8 weeks, while the normal-sodium salt group (NSSG) took the same dose of normal-sodium salt plus CM-DASH diet for 8 weeks. Blood tests, 24-hour urine tests, anthropometric measurements, and 10-year risk of ASCVD prediction were assessed. Results: compared with baseline, both LSSG and NSSG showed a significant reduction in 10-year risk of ASCVD, but we did not find any statistically significant differences in 10-year risk of ASCVD between LSSG and NSSG. Conclusions: our study shows that salt limits and DASH diets reduce the risk of cardiovascular disease whereas low-sodium salt containing 52 % sodium chloride did not significantly lower the risk of cardiovascular disease when compared to regular salt. Due to the limitations of the research, additional studies will be necessary to confirm our findings.